Zhang Long, Zeng Qianwen, Li Jinzhuo, Chen Nian, Tang Hui, Lei Xia, Wu Jinjin, Cheng Qionghui
Department of Dermatology, Daping Hospital, Army Medical University, Chongqing 400042, China.
Department of Dermatology, Daping Hospital, Army Medical University, Chongqing 400042, China.
Photodiagnosis Photodyn Ther. 2022 Dec;40:103048. doi: 10.1016/j.pdpdt.2022.103048. Epub 2022 Sep 29.
Condyloma acuminatum (CA) of the anal canal is difficult to treat and subject to relapse.. We investigated the effects of aminolevulinic acid-based photodynamic therapy (ALA-PDT) combined with oral acitretin during therapy of refractory CA in the anal canal. We also conducted a clinical retrospective study for the treatment of intra-anal CA.
A total of 101 patients diagnosed with intra-anal CA were enrolled. All patients underwent liquid nitrogen cryotherapy as a basic treatment until visible wart clearance. Patients were divided into two groups depending on the treatment modality after cryotherapy. ALA-PDT group with 51 patients was given ALA-PDT treatment, and ALA-PDT plus acitretin group with 50 patients was given ALA-PDT treatment combined with oral acitretin. The cure rate, recurrence rate, and adverse reactions of the two groups were analyzed and recorded.
The cure rate in the ALA-PDT plus acitretin group was 94% (47/50), which was significantly higher than 80.4% (41/51) in ALA-PDT group. The recurrence rate in the ALA-PDT plus acitretin group was 6% (3/50), which was lower than 19.6% (10/51) in ALA-PDT group (P<0.05).
ALA-PDT combined with oral acitretin is effective and safe in the treatment of refractory CA in anal canal, and with further study may become an option for these patients.
肛管尖锐湿疣(CA)难以治疗且易复发。我们研究了基于氨基酮戊酸的光动力疗法(ALA-PDT)联合口服阿维A在难治性肛管CA治疗中的效果。我们还对肛管内CA的治疗进行了临床回顾性研究。
共纳入101例诊断为肛管内CA的患者。所有患者均接受液氮冷冻治疗作为基础治疗,直至可见疣体清除。根据冷冻治疗后的治疗方式将患者分为两组。51例患者的ALA-PDT组接受ALA-PDT治疗,50例患者的ALA-PDT加阿维A组接受ALA-PDT治疗联合口服阿维A。分析并记录两组的治愈率、复发率及不良反应。
ALA-PDT加阿维A组的治愈率为94%(47/50),显著高于ALA-PDT组的80.4%(41/51)。ALA-PDT加阿维A组的复发率为6%(3/50),低于ALA-PDT组的19.6%(10/51)(P<0.05)。
ALA-PDT联合口服阿维A治疗难治性肛管CA有效且安全,进一步研究可能成为这些患者的一种选择。